What Daxxify is approved for
Glabellar (frown) lines in adults (2022). A separate approval (2023) covers cervical dystonia, a medical condition.
Treatment outside these areas is off-label, legal and common; it is discussed and consented to at your consultation.
When Dr. Toma reaches for Daxxify
- In the SAKURA phase 3 trials, the median duration of effect for frown lines was about 24 weeks. Some patients lost the effect sooner and some later, so planning is individual.
- Formulated with a stabilizing peptide (RTP004) rather than human serum albumin, which some patients prefer.
- Dosed on its own scale: 40 Daxxify units for the glabella. Units are not interchangeable with any other brand, and we never convert a dose.
Daxxify compared with Botox
| Daxxify | Botox | |
|---|---|---|
| Median duration in label trials | About 6 months | Typically about 3 to 4 months |
| Stabilizer | Peptide, no human albumin | Human serum albumin |
| Label areas | Glabellar lines | Glabella, crow's feet, forehead, platysma |
| Unit scale | Its own; 40 units for the glabella | Its own; not interchangeable |
Label wording verified Oct 2026. Units are not interchangeable between neurotoxin brands.
Cost of Daxxify in Naples
Pricing is shared in writing at your consultation and lists the product, amount per area and total before anything is placed. Prices carry their effective dates.
Questions about Daxxify
References: Daxxify prescribing information, BLA 761127 (Revance), glabellar lines 2022, cervical dystonia 2023 · SAKURA 1 and 2 phase 3 trials. Daxxify is a registered trademark of Revance. Individual results vary. This page is educational and not a substitute for a consultation.
